Skip to main content

mHealth India- Proof Of concept




Recent quote: “In the years to come, mHealth applications will be distributed primarily through healthcare distribution channels like hospitals and specialized healthcare product vendors and not the app stores as is currently the case, and that traditional will become the predominant distribution channel.”(Source: research2guidance)

Well this sounds promising. However, we all know that the success of a mHealth business model doesn’t depend on the distribution channel but on what you give for the money you take and in turn sustainability of that service”.

Positives: Growth of Smartphones market in India

India is witnessing a rapid growth in the smartphones segment. India shipped 4.8 lakh units of smartphones during Q3 CY2009. The top three smartphone vendors during Q3 of calender 2009 were Nokia, HTC and RIM. Together, these vendors had a share of nearly 90% of the Indian smartphones market in terms of unit shipments during the period July-September 2009. All the major handset makers like Nokia, HTC, LG, Motorola, Samsung etc are focusing on smartphone market this year. Launch of 3G technology in the Indian market will further accelerate the growth of Smartphones. With the number of smartphone users witnessing an upswing, prices are expected to see a phenomenal dip.

This means that after 5 years almost every value handset will have smartphone features..

How does these statistics affect the Business Scenario?

The end consumer will be immensely benefited. Smart phones will provide cost-savings, increased efficiency and a better quality of life. To give just one example, smartphones are being used as smart-health sensors, allowing heart patients to stay at home safely, while having their heart issues controlled and monitored by medical staff. In this way smartphones increase the patient’s quality of life and, at the same time, save healthcare costs.

...If we look at the mHealth business cases back in 2008, we will realize that with more value chain participants and higher costs of execution, there was very less reward (whether in the form of revenue gains or operational efficiencies) to go around. It therefore became progressively more difficult to achieve the financial impact that provides momentum and leads to partnership with larger players. Therefore today, with smartphones and other robust systems playing a volume game in mHealth, the latter will not be elusive anymore.

Efficient healthcare systems based on robust infrastructure like smartphones will drive revenue for all stakeholders in the next 5 years.

Which stakeholder will lead this Business?

It will be Mobile Operators/Carriers. Here is why:

Operators Define Connectivity: The progression of mHealth will largely be dependent on innovations in telecom and the speed of implementation of the same. 4G /LTE (Long-term evolution) will revolutionize the way data is sent over wireless networks. In the near future, I envision a scenario where a consumer can set up a telehealth appointment and get a physician consult leveraging the high speed wireless connection and high-def video conferencing capability right from his handset.

Hands on experience: Operators have a proven track record of implementing innovative technologies on a large scale (2G/3G/4G capability, smartphones connected to “app stores” with thousands of applications etc) and adapt them to different geographies in a highly competitive market.

Knowledge of Local customer needs: Deploying telecom solutions in various geographies and complying with local regulations, legal framework has enabled operators understand the local customer and their needs. Partnering with operators will enable organizations deliver specific solutions that meet local customer needs.

Already, Mobile operators have tremendous influence and strong relationships with handset manufacturers, and they should leverage this position to bring to market phones and other devices that can provide the mHealth and other mobile services consumers in developing countries need.

What is the way ahead for the torchbearer?

For POC, Operators should pro-actively seek out opportunities to improve health outcomes by initiating public-private partnerships, teaming up with governments and NGOs to address pressing national health issues, and collaborating with software providers to develop targeted healthcare solutions. Joint projects help ensure that key stakeholders are on board, increasing the potential for successful outcomes. As we discuss above that smartphones and robust healthcare systems will lead this foray, we can now afford and allow “n” number of stakeholders to get involved.

An Ideal mhealth Business Model Organization should be this way:

(Missing link= Yellow)







We should remember that while some of the role players will play a bigger role in driving the mHealth market, each and every player is a key ingredient in making this a service that the end-user will consume.

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki